Navigation Links
Voices Against Brain Cancer Awards Grant to Tocagen to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer
Date:6/21/2013

New York, NY (PRWEB) June 21, 2013

On June 21, Voices Against Brain Cancer (VABC), an organization dedicated to brain cancer research and advocacy, announces that it has awarded Tocagen Inc. a grant to support the clinical investigation of Toca 511 & Toca FC in patients diagnosed with a recurrent high grade glioma brain cancer (Grade 3 or Grade 4).

Tocagen Inc., the clinical trial sponsor, is developing the investigational drug Toca 511 in combination with Toca FC for the treatment of recurrent high grade glioma, including glioblastoma multiforme (GBM, Grade IV glioma) which is the most common and aggressive form of brain cancer. Tocagen is a privately held biopharmaceutical company developing novel treatments for advanced cancer, with an initial focus on brain cancer. They are presently enrolling patients in its investigational Phase I clinical trials at leading clinical trial sites across the United States.

Harry Gruber, M.D., and the CEO of Tocagen says, “We are very appreciative to VABC for supporting our clinical trials in patients with recurrent brain cancer. We are encouraged with our clinical data and plan to present updates at a future scientific conference.”

“Every day, progress is made in the search for a cure for this devastating disease,” says Mario Lichtenstein, Co-founder of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy. “Toca 511 & Toca FC is a promising new approach in clinical trials that has the potential to help patients with brain cancer, and we are excited to provide support for this program.”

VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, John Hopkins, Memorial Sloan-Kettering and Yale, to name a few.

VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.

For press inquiries, please contact: 5W Public Relations

Read the full story at http://www.prweb.com/releases/2013/6/prweb10853780.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voices Against Brain Cancer Commends Family For Remaining Positive Despite Three Cancer Diagnoses
2. Voices Against Brain Cancer Commends Father of Nine for Running Marathons Despite Diagnosis
3. Voices Against Brain Cancer Commends Brain Cancer Survivor For His Positive Outlook
4. Voices Against Brain Cancer Comments on New Discovery Made by Researchers in Regards to the Tie between Brain Cancer and Genetics
5. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
6. Voices Against Brain Cancer Commends Family for their Ongoing Efforts to Spread Brain Cancer Awareness
7. Avatar therapy helps silence voices in schizophrenia
8. Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells
9. Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle
10. Voices Against Brain Cancer Commends Mother for the Way She Honors Her Daughter’s Death
11. Voices Against Brain Cancer Applauds Mother For Starting Riah’s Rainbow Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... According to ... In an industry filled with chemical-laden beauty products, one company is going against the ... for you: Mad Hippie. The rising star in the green space is proud to ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... has been hired as FluidEdge’s Vice President of Business Intelligence and Informatics, effective ... Wolf has demonstrated success leading teams as a healthcare business and financial strategist ...
(Date:5/25/2016)... FL (PRWEB) , ... May ... ... has received the American Heart Association/American Stroke Association's Get With The Guidelines®-Stroke ... , This achievement, a second for Memorial Healthcare System, recognizes its ...
(Date:5/25/2016)... City, MO (PRWEB) , ... May 25, 2016 , ... ... collegiate, and amateur athletics, The National Center for Drug Free Sport (Drug Free Sport®) ... Free Sport”. This conference, to be held July 12 – 13 in Kansas City, ...
(Date:5/25/2016)... ... 25, 2016 , ... According to an article published April 14th ... effectively fight against common bacteria and protect against surgical site infections. The article explains ... repair surgery even safer and could further reduce the risk of surgery related ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- According to Kalorama Information, the world market for ... these are challenging times in the market, there ... companies that remain optimistic and seek innovation.  Toward ... medical device companies spend a higher percentage of ... do companies in other industries.  Also, in addition ...
(Date:5/25/2016)... 2016 MedDay, a biotechnology company focused ... oral presentation entitled "High doses of biotin in progressive multiple ... given by Professor Ayman Tourbah , Principal Investigator of ... European Academy of Neurology (EAN) in Copenhagen, Denmark ... will take place on Sunday, 29 May 2016 from 14:45 ...
(Date:5/24/2016)... 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der ... ‚ausgezeichneter plus guter , Reinigung ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... Daten von der MORA-Studie der Phase III für ...
Breaking Medicine Technology: